Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-25-012239

President and CEO acquired 427,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KIDRON NADAV President and CEO 2025-02-11 Grant or award +141,000 2,400,598 D
KIDRON NADAV President and CEO 2025-02-11 Grant or award +186,000 2,586,598 D
KIDRON NADAV President and CEO 2025-02-11 Grant or award +100,000 2,686,598 D
Loading xslF345X05/ownership.xml…